Latest Sales And Development News

Summerset Group Holdings Limited reported a robust first half in 2025, with underlying profit up 19% and record sales driving momentum across New Zealand and Australia.

Invion Limited posted a $8.8 million loss for FY25, marking a 56.5% increase, while advancing clinical trials and securing fresh capital. The biotech faces a going concern warning amid ongoing development and funding challenges.

Rural Funds Group reported FY25 results aligned with forecasts, showcasing steady distributions and a diversified agricultural portfolio. The group maintains solid gearing and advances key development projects while forecasting stable AFFO and distributions for FY26.

Duxton Farms reported a significant $12.5 million net loss for FY2025, reversing last year’s profit, while declaring an 85% franked dividend of 24 cents per share. The company’s revenue dipped due to property sales and increased expenses tied to a proposed acquisition.

First Graphene Limited reports over A$1.2 million in annual income, driven by new commercial orders and breakthrough graphene applications in mining safety boots and cement additives.

Vanadium Resources Limited has secured a binding two-year offtake agreement for vanadium-rich magnetite ore and raised A$1.2 million, advancing its near-term production plans at the Steelpoortdrift project.

Norwood Systems delivered its strongest quarter yet with record cash inflows, significant debt reduction, and expanding global partnerships, setting a robust foundation for FY2026.

Vitasora Health has completed the first tranche of its $11 million capital raise, positioning the company to fund growth initiatives and reach cash flow breakeven in the second half of fiscal 2026.

Xero Limited has agreed to acquire Melio Limited, a leading US SMB bill pay platform, for US$2.5 billion, marking a significant leap in its US growth strategy. The deal is backed by a substantial A$1.85 billion equity raise and aims to accelerate revenue and market presence by FY28.

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.

Opyl Limited has successfully raised $1.5 million through an oversubscribed placement to accelerate the growth of its AI-driven clinical trial platform, Trialkey. The capital injection underscores strong investor confidence as the company prepares for a pivotal expansion phase.

Jindalee Lithium advances its McDermitt Lithium Project in the US with a robust 63-year Pre-Feasibility Study, enhanced permitting progress, and strong US government support under the FAST-41 initiative. Strategic partnerships and funding efforts are underway to de-risk and develop this critical mineral asset.